日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

野生型和阿尔茨海默病样 APP/PS1 小鼠衰老过程中的胶质血管变化

Janota C S, Brites D, Lemere C A, Brito M A

Amyloid-beta immunotherapy for Alzheimer's disease

阿尔茨海默病淀粉样蛋白β免疫疗法

Fu, H J; Liu, B; Frost, J L; Lemere, C A

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

针对淀粉样蛋白肽聚集体的神经保护性天然抗体随着正常衰老和阿尔茨海默病进展而减少

Britschgi, M; Olin, C E; Johns, H T; Takeda-Uchimura, Y; LeMieux, M C; Rufibach, K; Rajadas, J; Zhang, H; Tomooka, B; Robinson, W H; Clark, C M; Fagan, A M; Galasko, D R; Holtzman, D M; Jutel, M; Kaye, J A; Lemere, C A; Leszek, J; Li, G; Peskind, E R; Quinn, J F; Yesavage, J A; Ghiso, J A; Wyss-Coray, T

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease

唐氏综合征合并阿尔茨海默病患者淀粉样斑块中补体蛋白的暂时性积累

Stoltzner, S E; Grenfell, T J; Mori, C; Wisniewski, K E; Wisniewski, T M; Selkoe, D J; Lemere, C A

Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S

溶酶体将淀粉样前体蛋白加工成Aβ肽:组织蛋白酶S的独特作用

Munger, J S; Haass, C; Lemere, C A; Shi, G P; Wong, W S; Teplow, D B; Selkoe, D J; Chapman, H A